Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morvarid Karimi

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2010
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?Morvarid Karimi, Stephen M Moerlein, Tom O Videen, et al.
Plos One|February 24, 2012
No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson diseaseLinLin Tian, Morvarid Karimi, Susan K Loftin, et al.
EJNMMI Research|July 7, 2025
Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand <sup>18</sup>F-VAT in humansScott A Norris, Noah L Goldman, Mahdjoub Hamdi, et al.
Journal of Neurophysiology|July 10, 2024
Differential components of bradykinesia in Parkinson's disease revealed by deep brain stimulationPietro Mazzoni, Mwiza Ushe, John R Younce, et al.
Plos One|September 6, 2018
Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaquesJoshua S Shimony, Jerrel Rutlin, Morvarid Karimi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2006
Relative risk of spread of symptoms among the focal onset primary dystoniasElliott M Weiss, Tamara Hershey, Morvarid Karimi, et al.
Experimental Neurology|March 11, 2008
Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson diseaseSamer D Tabbal, Mwiza Ushe, Jonathan W Mink, et al.
Annals of Neurology|February 21, 2013
Validation of nigrostriatal positron emission tomography measures: critical limitsMorvarid Karimi, LinLin Tian, Christopher A Brown, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2017
Absorbed radiation dosimetry of the D<sub>3</sub>-specific PET radioligand [<sup>18</sup>F]FluorTriopride estimated using rodent and nonhuman primateRichard Laforest, Morvarid Karimi, Stephen M Moerlein, et al.
Brain : a Journal of Neurology|September 22, 2010
Mapping Go-No-Go performance within the subthalamic nucleus regionTamara Hershey, Meghan C Campbell, Tom O Videen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2010
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?Morvarid Karimi, Stephen M Moerlein, Tom O Videen, et al.
Plos One|February 24, 2012
No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson diseaseLinLin Tian, Morvarid Karimi, Susan K Loftin, et al.
EJNMMI Research|July 7, 2025
Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand <sup>18</sup>F-VAT in humansScott A Norris, Noah L Goldman, Mahdjoub Hamdi, et al.
Journal of Neurophysiology|July 10, 2024
Differential components of bradykinesia in Parkinson's disease revealed by deep brain stimulationPietro Mazzoni, Mwiza Ushe, John R Younce, et al.
Plos One|September 6, 2018
Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaquesJoshua S Shimony, Jerrel Rutlin, Morvarid Karimi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2006
Relative risk of spread of symptoms among the focal onset primary dystoniasElliott M Weiss, Tamara Hershey, Morvarid Karimi, et al.
Experimental Neurology|March 11, 2008
Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson diseaseSamer D Tabbal, Mwiza Ushe, Jonathan W Mink, et al.
Annals of Neurology|February 21, 2013
Validation of nigrostriatal positron emission tomography measures: critical limitsMorvarid Karimi, LinLin Tian, Christopher A Brown, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2017
Absorbed radiation dosimetry of the D<sub>3</sub>-specific PET radioligand [<sup>18</sup>F]FluorTriopride estimated using rodent and nonhuman primateRichard Laforest, Morvarid Karimi, Stephen M Moerlein, et al.
Brain : a Journal of Neurology|September 22, 2010
Mapping Go-No-Go performance within the subthalamic nucleus regionTamara Hershey, Meghan C Campbell, Tom O Videen, et al.
Pageof 4